Literature DB >> 31747588

NPGPx-Mediated Adaptation to Oxidative Stress Protects Motor Neurons from Degeneration in Aging by Directly Modulating O-GlcNAcase.

Yung-Lin Hsieh1, Fang-Yi Su2, Li-Kai Tsai3, Chien-Chang Huang1, Yi-Ling Ko1, Li-Wen Su1, Kai-Yun Chen4, Hsiu-Ming Shih5, Chun-Mei Hu1, Wen-Hwa Lee6.   

Abstract

Amyotrophic lateral sclerosis (ALS), the most common motor neuron disease, usually occurs in middle-aged people. However, the molecular basis of age-related cumulative stress in ALS pathogenesis remains elusive. Here, we found that mice deficient in NPGPx (GPx7), an oxidative stress sensor, develop ALS-like phenotypes, including paralysis, muscle denervation, and motor neurons loss. Unlike normal spinal motor neurons that exhibit elevated O-GlcNAcylation against age-dependent oxidative stress, NPGPx-deficient spinal motor neurons fail to boost O-GlcNAcylation and exacerbate ROS accumulation, leading to cell death. Mechanistically, stress-activated NPGPx inhibits O-GlcNAcase (OGA) through disulfide bonding to fine-tune global O-GlcNAcylation. Pharmacological inhibition of OGA rescues spinal motor neuron loss in aged NPGPx-deficient mice. Furthermore, expression of NPGPx in ALS patients is significantly lower than in unaffected adults. These results suggest that NPGPx modulates O-GlcNAcylation by inhibiting OGA to cope with age-dependent oxidative stress and protect motor neurons from degeneration, providing a potential therapeutic axis for ALS.
Copyright © 2019 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ALS; NPGPx; O-GlcNAcylation; OGA; aging; motor neuron; oxidative stress

Year:  2019        PMID: 31747588     DOI: 10.1016/j.celrep.2019.10.053

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  7 in total

Review 1.  Emerging molecular mediators and targets for age-related skeletal muscle atrophy.

Authors:  Lemuel A Brown; Steve D Guzman; Susan V Brooks
Journal:  Transl Res       Date:  2020-03-10       Impact factor: 7.012

2.  O-GlcNAcylation of TDP-43 suppresses proteinopathies and promotes TDP-43's mRNA splicing activity.

Authors:  Meng-Jie Zhao; Xiao Yao; Ping Wei; Chen Zhao; Meng Cheng; Dong Zhang; Wen Xue; Wen-Tian He; Weili Xue; Xinxin Zuo; Lei-Lei Jiang; Zhiyuan Luo; Jiaqi Song; Wen-Jie Shu; Han-Ye Yuan; Yi Liang; Hui Sun; Yan Zhou; Yu Zhou; Ling Zheng; Hong-Yu Hu; Jiwu Wang; Hai-Ning Du
Journal:  EMBO Rep       Date:  2021-04-15       Impact factor: 9.071

Review 3.  Intracellular Sources of ROS/H2O2 in Health and Neurodegeneration: Spotlight on Endoplasmic Reticulum.

Authors:  Tasuku Konno; Eduardo Pinho Melo; Joseph E Chambers; Edward Avezov
Journal:  Cells       Date:  2021-01-25       Impact factor: 6.600

Review 4.  O-GlcNAcylation in health and neurodegenerative diseases.

Authors:  Byeong Eun Lee; Pann-Ghill Suh; Jae-Ick Kim
Journal:  Exp Mol Med       Date:  2021-11-26       Impact factor: 8.718

5.  Comprehensive analysis of epigenetics regulation, prognostic and the correlation with immune infiltrates of GPX7 in adult gliomas.

Authors:  Wallax Augusto Silva Ferreira; Glauco Akelinghton Freire Vitiello; Tiago da Silva Medina; Edivaldo Herculano Correa de Oliveira
Journal:  Sci Rep       Date:  2022-04-19       Impact factor: 4.996

6.  Loss of O-GlcNAcase catalytic activity leads to defects in mouse embryogenesis.

Authors:  Villő Muha; Florence Authier; Zsombor Szoke-Kovacs; Sara Johnson; Jennifer Gallagher; Alison McNeilly; Rory J McCrimmon; Lydia Teboul; Daan M F van Aalten
Journal:  J Biol Chem       Date:  2021-02-19       Impact factor: 5.157

7.  A missense mutation in a patient with developmental delay affects the activity and structure of the hexosamine biosynthetic pathway enzyme AGX1.

Authors:  Xiping Chen; Olawale G Raimi; Andrew T Ferenbach; Daan M F van Aalten
Journal:  FEBS Lett       Date:  2020-11-18       Impact factor: 3.864

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.